4//SEC Filing
Johnson Anne Nagengast 4
Accession 0001140361-25-007206
CIK 0001840904other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:28 PM ET
Size
5.1 KB
Accession
0001140361-25-007206
Insider Transaction Report
Form 4
Johnson Anne Nagengast
Chief Financial Officer
Transactions
- Award
Stock Option
2025-03-03+757,915→ 757,915 totalExercise: $1.50Exp: 2035-03-03→ Common Shares (757,915 underlying)
Footnotes (1)
- [F1]The stock option shall vest as to 25% on January 1, 2026, with the remaining shares vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
ATAI Life Sciences N.V.
CIK 0001840904
Entity typeother
Related Parties
1- filerCIK 0001976640
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:28 PM ET
- Size
- 5.1 KB